These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 11581582)

  • 1. Another long-acting methylphenidate (Metadate CD).
    Med Lett Drugs Ther; 2001 Oct; 43(1114):83-4. PubMed ID: 11581582
    [No Abstract]   [Full Text] [Related]  

  • 2. A new long-acting methylphenidate (Concerta).
    Med Lett Drugs Ther; 2000 Sep; 42(1086):80-1. PubMed ID: 10980811
    [No Abstract]   [Full Text] [Related]  

  • 3. Sustained-release methylphenidate: new preparations. New pharmaceutical forms: a slight advantage for a small number of children.
    Prescrire Int; 2004 Dec; 13(74):203-6. PubMed ID: 15612099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of long-acting OROS methylphenidate on routine driving in young adults with attention-deficit/hyperactivity disorder.
    Cox DJ; Mikami AY; Cox BS; Coleman MT; Mahmood A; Sood A; Moore M; Burket R; Merkel RL
    Arch Pediatr Adolesc Med; 2008 Aug; 162(8):793-4. PubMed ID: 18678816
    [No Abstract]   [Full Text] [Related]  

  • 5. Efficacy of two once-daily methylphenidate formulations compared across dose levels at different times of the day: preliminary indications from a secondary analysis of the COMACS study data.
    Sonuga-Barke EJ; Swanson JM; Coghill D; DeCory HH; Hatch SJ
    BMC Psychiatry; 2004 Sep; 4():28. PubMed ID: 15458569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Letter to the editor: Comment on 'Acute impact of immediate release methylphenidate administered three times a day on sleep in children with attention-deficit/hyperactivity disorder'.
    Olders H
    J Pediatr Psychol; 2009; 34(1):108-9; author reply 110-2. PubMed ID: 19136567
    [No Abstract]   [Full Text] [Related]  

  • 7. Methylphenidate controlled-delivery capsules (EquasymXL, Metadate CD): a review of its use in the treatment of children and adolescents with attention-deficit hyperactivity disorder.
    Anderson VR; Keating GM
    Paediatr Drugs; 2006; 8(5):319-33. PubMed ID: 17037949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sustained-release methylphenidate.
    Med Lett Drugs Ther; 1984 Oct; 26(673):97-8. PubMed ID: 6384753
    [No Abstract]   [Full Text] [Related]  

  • 9. Slow-release methylphenidate: problems when children chew tablets.
    Rosse RB; Licamele WL
    J Clin Psychiatry; 1984 Dec; 45(12):525. PubMed ID: 6501242
    [No Abstract]   [Full Text] [Related]  

  • 10. Continuity of methylphenidate treatment for attention-deficit/hyperactivity disorder.
    Marcus SC; Wan GJ; Kemner JE; Olfson M
    Arch Pediatr Adolesc Med; 2005 Jun; 159(6):572-8. PubMed ID: 15939858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Full-day ADHD symptom control that "lasts from home to homework".
    Pediatr Nurs; 2000; 26(6):634-5. PubMed ID: 12026370
    [No Abstract]   [Full Text] [Related]  

  • 12. Aptensio XR--another long-acting methylphenidate.
    Med Lett Drugs Ther; 2015 Jul; 57(1473):101-3. PubMed ID: 26204039
    [No Abstract]   [Full Text] [Related]  

  • 13. Focalin XR for ADHD.
    Med Lett Drugs Ther; 2009 Mar; 51(1308):22-4. PubMed ID: 19305368
    [No Abstract]   [Full Text] [Related]  

  • 14. Multisite controlled study of OROS methylphenidate in the treatment of adolescents with attention-deficit/hyperactivity disorder.
    Wilens TE; McBurnett K; Bukstein O; McGough J; Greenhill L; Lerner M; Stein MA; Conners CK; Duby J; Newcorn J; Bailey CE; Kratochvil CJ; Coury D; Casat C; Denisco MJ; Halstead P; Bloom L; Zimmerman BA; Gu J; Cooper KM; Lynch JM
    Arch Pediatr Adolesc Med; 2006 Jan; 160(1):82-90. PubMed ID: 16389216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Flawed attention-deficit/hyperactivity disorder medication comparison.
    Adesman A
    Pediatrics; 2004 Oct; 114(4):1132; author reply 1132-3. PubMed ID: 15466129
    [No Abstract]   [Full Text] [Related]  

  • 16. Amphetamine-type drugs for hyperactive children.
    Med Lett Drugs Ther; 1972 Mar; 14(7):21-3. PubMed ID: 4648553
    [No Abstract]   [Full Text] [Related]  

  • 17. Symposium: behavior modification by drugs. 3. The clinical use of stimulant drugs in children.
    Eisenberg L
    Pediatrics; 1972 May; 49(5):709-15. PubMed ID: 4504174
    [No Abstract]   [Full Text] [Related]  

  • 18. Clonidine for stimulant-related sleep problems.
    Rubinstein S; Silver LB; Licamele WL
    J Am Acad Child Adolesc Psychiatry; 1994 Feb; 33(2):281-2. PubMed ID: 8150803
    [No Abstract]   [Full Text] [Related]  

  • 19. Spotlight on methylphenidate controlled-delivery capsules (Equasym XL, Metadate CD) in the treatment of children and adolescents with attention-deficit hyperactivity disorder.
    Anderson VR; Keating GM
    CNS Drugs; 2007; 21(2):173-5. PubMed ID: 17284098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bioavailability of modified-release methylphenidate: influence of high-fat breakfast when administered intact and when capsule content sprinkled on applesauce.
    Lee L; Kepple J; Wang Y; Freestone S; Bakhtiar R; Wang Y; Hossain M
    Biopharm Drug Dispos; 2003 Sep; 24(6):233-43. PubMed ID: 12973820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.